76-90 of 127
Narcolepsy’s Burden of Illness: Its Impact on the Child and Family
MinuteCE®Narcolepsy’s Burden of Illness: Its Impact on the Child and Family
Anne M. Morse, DO
Kiran Maski, MD, MPH
Pediatric Narcolepsy: Psychological and Social Comorbidities
MinuteCE®Pediatric Narcolepsy: Psychological and Social Comorbidities
Kiran Maski, MD, MPH
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
MinuteCE®Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Kiran Maski, MD, MPH
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Anne M. Morse, DO
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Funke Afolabi-Brown, MD
- advertisement
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
MinuteCE®Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Anne M. Morse, DO
Overcoming Clinical Inertia in Hyperkalemia Management
CME/CEOvercoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD
Luca De Nicola, MD, PhD
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®CASR and ADH1: Integrating Biology and Genetic Screening
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®Therapeutic Options for ADH1 and Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
- advertisement
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®Emerging Therapeutics in ADH1: Progress in Precision Medicine
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CERevolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Hyperkalemia in CKD and HFrEF…What Am I Missing?
CME/CEHyperkalemia in CKD and HFrEF…What Am I Missing?
George Bakris
David Bushinsky, MD
Lars Lund, MD
